Axitan expands fermentation team with appointment of Sam Romes

Axitan Limited, a leading biotech company focused on the development of endolysin enzyme products to replace antibiotics in animal feed, today announces the appointment of Sam Romes as Senior Bioprocessing Engineer. He will be responsible for managing the Company’s fermentation processes and overseeing technology transfers to Contract Manufacturing Organisations as the Company builds out its global CMO network.

Al Zimmerman, CEO of Axitan, commented:

“Sam brings a wealth of leading-edge, large-scale, precision fermentation experience to Axitan making him an ideal fit to the team as commercial sale volumes of our first endolysin-based product, FORC3®, continue to build.”

Sam Romes added:

“It is a great honour to have joined this fast-growing business focused on the reduction and removal of antibiotics in animal feed through endolysin-based solutions.”